Refine
Has Fulltext
- yes (20)
Is part of the Bibliography
- yes (20)
Document Type
- Journal article (20)
Language
- English (20)
Keywords
- cancer (4)
- breast-tumors (3)
- oncolytic viruses (3)
- systematic review (3)
- Lung cancer (2)
- angiogenesis (2)
- cancer treatment (2)
- microenvironment (2)
- nude-mice (2)
- postoperative nausea and vomiting (2)
- therapy (2)
- vaccinia virus (2)
- Agent (1)
- BV-2 (1)
- Biochemie (1)
- Biologie (1)
- Breast-tumors (1)
- COVID-19 (1)
- COVID-19 pandemic (1)
- COX-2 (1)
- Cancer (1)
- Chemotherapy (1)
- Combination therapy (1)
- Cyclophosphamide (1)
- GBM (1)
- IMA2.1 (1)
- In-vivo (1)
- Inhibitor (1)
- Krebs <Medizin> (1)
- Lungenkrebs (1)
- Malignant effusion (1)
- Nude-mice (1)
- OSC (1)
- Oncolytic virotherapy (1)
- Tissue (1)
- VACV (1)
- VEGF (1)
- Vaccinia virus (1)
- Vascular endothelial Growth Factor (1)
- Virusinfektion (1)
- adenovirus (1)
- analgesics (1)
- animal-model (1)
- antibodies (1)
- anticoagulant therapy (1)
- antiemetics (1)
- awake prone positioning (1)
- bleeding (1)
- carcinoma (1)
- carcinomas (1)
- cell cultures (1)
- cell-line (1)
- chemotherapy (1)
- clinical trial (1)
- conference abstracts (1)
- coronavirus disease 2019 (1)
- cytokine (1)
- death (1)
- dogs (1)
- endothelial growth-factor (1)
- enhanced recovery after surgery (1)
- enzyme-linked immunoassays (1)
- epidural analgesia (1)
- evidence synthesis (1)
- fluorescence imaging (1)
- fluorescence microscopy (1)
- glv-1h68 (1)
- good clinical practice (1)
- high-flow nasal cannula (1)
- histology (1)
- hyper-IL-6 (1)
- in vivo imaging (1)
- in-vitro (1)
- inflammation (1)
- kidneys (1)
- lung and intrathoracic tumors (1)
- lymph nodes (1)
- macrophages (1)
- magnetic resonance imaging (1)
- matrix metalloproteinases (1)
- meta-analysis (1)
- metastasis (1)
- mice (1)
- microglia (1)
- microvascular density (1)
- model (1)
- multimodal treatments (1)
- network meta-analysis (1)
- neutrophils (1)
- non-invasive ventilation (1)
- oncolysis (1)
- perioperative care (1)
- pet dogs (1)
- polarization (1)
- prostate (1)
- randomized controlled trial (1)
- renal cancer (1)
- research integrity (1)
- respiratory failure (1)
- secondary lung tumors (1)
- selective outcome reporting (1)
- systematic review, (1)
- systemic reviews (1)
- thrombosis (1)
- trial registration (1)
- tumor microenvironment (1)
- viral replication (1)
- virotherapy (1)
- vomiting (1)
Institute
Background: Acute respiratory failure is the most important organ dysfunction of COVID-19 patients. While non-invasive ventilation (NIV) and high-flow nasal cannula (HFNC) oxygen are frequently used, efficacy and safety remain uncertain. Benefits and harms of awake prone positioning (APP) in COVID-19 patients are unknown. Methods: We searched for randomized controlled trials (RCTs) comparing HFNC vs. NIV and APP vs. standard care. We meta-analyzed data for mortality, intubation rate, and safety. Results: Five RCTs (2182 patients) were identified. While it remains uncertain whether HFNC compared to NIV alters mortality (RR: 0.92, 95% CI 0.65–1.33), HFNC may increase rate of intubation or death (composite endpoint; RR 1.22, 1.03–1.45). We do not know if HFNC alters risk for harm. APP compared to standard care probably decreases intubation rate (RR 0.83, 0.71–0.96) but may have little or no effect on mortality (RR: 1.08, 0.51–2.31). Conclusions: Certainty of evidence is moderate to very low. There is no compelling evidence for either HFNC or NIV, but both carry substantial risk for harm. The use of APP probably has benefits although mortality appears unaffected.